AtriCure Total Liabilities 2010-2023 | ATRC

AtriCure total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
AtriCure Annual Total Liabilities
(Millions of US $)
2023 $148
2022 $129
2021 $132
2020 $302
2019 $311
2018 $107
2017 $107
2016 $108
2015 $86
2014 $26
2013 $39
2012 $20
2011 $18
2010 $17
2009 $18
AtriCure Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $148
2023-09-30 $137
2023-06-30 $132
2023-03-31 $128
2022-12-31 $129
2022-09-30 $132
2022-06-30 $131
2022-03-31 $122
2021-12-31 $132
2021-09-30 $125
2021-06-30 $316
2021-03-31 $309
2020-12-31 $302
2020-09-30 $290
2020-06-30 $287
2020-03-31 $300
2019-12-31 $311
2019-09-30 $303
2019-06-30 $102
2019-03-31 $99
2018-12-31 $107
2018-09-30 $108
2018-06-30 $111
2018-03-31 $117
2017-12-31 $107
2017-09-30 $110
2017-06-30 $107
2017-03-31 $106
2016-12-31 $108
2016-09-30 $106
2016-06-30 $105
2016-03-31 $81
2015-12-31 $86
2015-09-30 $40
2015-06-30 $31
2015-03-31 $25
2014-12-31 $26
2014-09-30 $22
2014-06-30 $22
2014-03-31 $24
2013-12-31 $39
2013-09-30 $21
2013-06-30 $19
2013-03-31 $20
2012-12-31 $20
2012-09-30 $20
2012-06-30 $21
2012-03-31 $22
2011-12-31 $18
2011-09-30 $18
2011-06-30 $19
2011-03-31 $21
2010-12-31 $17
2010-09-30 $20
2010-06-30 $19
2010-03-31 $17
2009-12-31 $18
2009-09-30 $18
2009-06-30 $13
2009-03-31 $6
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.115B $0.399B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.474B 24.35
Stryker (SYK) United States $128.161B 31.78
Boston Scientific (BSX) United States $106.966B 34.07
Medtronic (MDT) Ireland $106.730B 15.11
EssilorLuxottica (ESLOY) France $99.574B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.648B 0.00
Haleon (HLN) United Kingdom $38.127B 29.82
ResMed (RMD) United States $27.032B 27.03
Terumo (TRUMY) Japan $25.476B 35.98
Zimmer Biomet Holdings (ZBH) United States $24.896B 16.03
Baxter (BAX) United States $20.785B 15.16
Koninklijke Philips (PHG) Netherlands $19.474B 15.53
Insulet (PODD) United States $11.711B 61.49
Smith & Nephew SNATS (SNN) United Kingdom $10.741B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.934B 23.64
BellRing Brands (BRBR) United States $7.285B 39.17
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.379B 22.40
Perrigo (PRGO) Ireland $4.232B 12.10
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Envista Holdings (NVST) United States $3.485B 13.26
Prestige Consumer Healthcare (PBH) United States $3.482B 16.46
QuidelOrtho (QDEL) United States $2.730B 9.91
Neogen (NEOG) United States $2.679B 25.77
Green Thumb Industries (GTBIF) United States $2.630B 83.33
ICU Medical (ICUI) United States $2.357B 17.58
TG Therapeutics (TGTX) United States $2.161B 699.00
Maravai LifeSciences Holdings (MRVI) United States $1.928B 0.00
Owens & Minor (OMI) United States $1.895B 18.19
Verano Holdings (VRNOF) United States $1.790B 0.00
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
InMode (INMD) Israel $1.458B 7.55
LeMaitre Vascular (LMAT) United States $1.437B 47.43
National Vision Holdings (EYE) United States $1.388B 43.24
AdaptHealth (AHCO) United States $1.300B 9.78
Warby Parker (WRBY) United States $1.287B 0.00
MacroGenics (MGNX) United States $0.982B 0.00
Canopy Growth (CGC) Canada $0.899B 0.00
BioLife Solutions (BLFS) United States $0.779B 0.00
Cresco Labs (CRLBF) United States $0.712B 0.00
VAREX IMAGING (VREX) United States $0.693B 14.98
Evolus (EOLS) United States $0.666B 0.00
Quanterix (QTRX) United States $0.613B 0.00
Jin Medical (ZJYL) China $0.547B 0.00
Valneva SE (VALN) France $0.540B 0.00
Phibro Animal Health (PAHC) United States $0.509B 11.02
PetIQ (PETQ) United States $0.487B 18.17
TerrAscend (TSNDF) Canada $0.478B 0.00
ZimVie (ZIMV) United States $0.430B 26.35
OraSure Technologies (OSUR) United States $0.421B 6.96
Biote (BTMD) United States $0.417B 3.96
Aurora Cannabis (ACB) Canada $0.393B 0.00
Surmodics (SRDX) United States $0.371B 40.11
Zynex (ZYXI) United States $0.361B 41.59
Viemed Healthcare (VMD) United States $0.314B 31.11
Cerus (CERS) United States $0.301B 0.00
Sanara MedTech (SMTI) United States $0.280B 0.00
TriSalus Life Sciences (TLSI) United States $0.274B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.70
Organigram Holdings (OGI) Canada $0.199B 0.00
Veru (VERU) United States $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.192B 0.00
Omeros (OMER) United States $0.176B 0.00
Quipt Home Medical (QIPT) United States $0.163B 0.00
High Tide (HITI) Canada $0.160B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Jushi Holdings (JUSHF) United States $0.134B 0.00
Eagleford Energy (GRUSF) United States $0.130B 65.20
FitLife Brands (FTLF) United States $0.129B 20.74
InterCure (INCR) Israel $0.122B 20.54
Fonar (FONR) United States $0.102B 8.80
Cellectar Biosciences (CLRB) United States $0.099B 0.00
MariMed (MRMD) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Allurion Technologies (ALUR) United States $0.088B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.060B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.059B 3.86
Apyx Medical (APYX) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 15.04
Bright Green (BGXX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Agape ATP (ATPC) $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 72.54
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00